BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21108661)

  • 21. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
    DeMartelaere SL; Roberts D; Burgess MA; Morrison WH; Pisters PW; Sturgis EM; Ho V; Esmaeli B
    Head Neck; 2008 May; 30(5):639-46. PubMed ID: 18213722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pegylated liposomal doxorubicin in the treatment of mycosis fungoides.
    Lybaek D; Iversen L
    Acta Derm Venereol; 2006; 86(6):545-7. PubMed ID: 17106606
    [No Abstract]   [Full Text] [Related]  

  • 24. Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
    Quéreux G; Renaut JJ; Peuvrel L; Knol AC; Brocard A; Dréno B
    Acta Derm Venereol; 2010 Nov; 90(6):616-20. PubMed ID: 21057746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low to moderate cumulative doses of pegylated liposomal doxorubicin in the treatment of classic Kaposi sarcoma in elderly patients with comorbidities.
    Potouridou I; Korfitis C; Ioannidou D; Polydorou D; Zakopoulou N; Stratigos AJ; Katsambas AD
    Br J Dermatol; 2008 Feb; 158(2):431-2. PubMed ID: 18067475
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain metastases in relapsed epithelial ovarian cancer after chemotherapy with pegylated liposomal doxorubicin.
    Kasprowicz NS; Fotopoulou C; Oskay-Ozcelik G; El KK; Boehmer D; Sehouli J
    Anticancer Res; 2008; 28(3B):1943-6. PubMed ID: 18630485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of pegylated liposomal doxorubicin in ovarian cancer.
    Thigpen JT; Aghajanian CA; Alberts DS; Campos SM; Gordon AN; Markman M; McMeekin DS; Monk BJ; Rose PG
    Gynecol Oncol; 2005 Jan; 96(1):10-8. PubMed ID: 15589573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma.
    Hau P; Fabel K; Baumgart U; Rümmele P; Grauer O; Bock A; Dietmaier C; Dietmaier W; Dietrich J; Dudel C; Hübner F; Jauch T; Drechsel E; Kleiter I; Wismeth C; Zellner A; Brawanski A; Steinbrecher A; Marienhagen J; Bogdahn U
    Cancer; 2004 Mar; 100(6):1199-207. PubMed ID: 15022287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated liposomal doxorubicin treatment in recurrent gynecologic cancer patients with renal dysfunction.
    Li Y; Finkel KW; Hu W; Fu S; Liu J; Coleman R; Kavanagh JJ
    Gynecol Oncol; 2007 Aug; 106(2):375-80. PubMed ID: 17512575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rapidly progressing course of cutaneous angiosarcoma in the area of the head-neck].
    Jund R; Nerlich A; Jäger L; Grevers G
    Laryngorhinootologie; 1999 Oct; 78(10):557-60. PubMed ID: 10595340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A modified regimen of pegylated liposomal doxorubicin, bortezomib, and dexamethasone is effective and well tolerated in the treatment of relapsed or refractory multiple myeloma.
    Waterman GN; Yellin O; Swift RA; Mapes R; Eades B; Ackerman E; Berenson JR
    Ann Hematol; 2011 Feb; 90(2):193-200. PubMed ID: 20809423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of recurrent platinum-resistant ovarian cancer with pegylated liposomal doxorubicin--an evaluation of the therapeutic index with special emphasis on cardiac toxicity.
    Steppan I; Reimer D; Sevelda U; Ulmer H; Marth C; Zeimet AG
    Chemotherapy; 2009; 55(6):391-8. PubMed ID: 19955744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T; Henry D; Tonda M; Sun S; O'Connell M; Rackoff W
    Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO.
    Oskay-Oezcelik G; Koensgen D; Hindenburg HJ; Klare P; Schmalfeldt B; Lichtenegger W; Chekerov R; Al-Batran SE; Neumann U; Sehouli J;
    Anticancer Res; 2008; 28(2B):1329-34. PubMed ID: 18505074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.
    Skubitz KM; Haddad PA
    Cancer; 2005 Jul; 104(2):361-6. PubMed ID: 15948172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy.
    Ohguri T; Imada H; Nomoto S; Yahara K; Hisaoka M; Hashimoto H; Tokura Y; Nakamura K; Shioyama Y; Honda H; Terashima H; Moroi Y; Furue M; Korogi Y
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1446-53. PubMed ID: 15817349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined surgical and X-ray treatment for angiosarcoma of the scalp: report of a case with a favourable outcome.
    Brand CU; Yawalkar N; von Briel C; Hunziker T
    Br J Dermatol; 1996 Apr; 134(4):763-5. PubMed ID: 8733388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous epithelioid angiosarcoma: a neoplasm with potential pitfalls in diagnosis.
    Mobini N
    J Cutan Pathol; 2009 Mar; 36(3):362-9. PubMed ID: 19220634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Rose PG; Blessing JA; Lele S; Abulafia O
    Gynecol Oncol; 2006 Aug; 102(2):210-3. PubMed ID: 16478630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.